Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3137877
Max Phase: Preclinical
Molecular Formula: C34H52O
Molecular Weight: 476.79
Molecule Type: Small molecule
Associated Items:
ID: ALA3137877
Max Phase: Preclinical
Molecular Formula: C34H52O
Molecular Weight: 476.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4[C@H](Cc5ccccc5)C(=O)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C34H52O/c1-23(2)10-9-11-24(3)28-16-17-29-26-14-15-30-27(22-25-12-7-6-8-13-25)32(35)19-21-34(30,5)31(26)18-20-33(28,29)4/h6-8,12-13,23-24,26-31H,9-11,14-22H2,1-5H3/t24-,26+,27+,28-,29+,30+,31+,33-,34+/m1/s1
Standard InChI Key: LUQXAMMVDIOGHR-AFXVPYTDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 476.79 | Molecular Weight (Monoisotopic): 476.4018 | AlogP: 9.15 | #Rotatable Bonds: 7 |
Polar Surface Area: 17.07 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 9.85 | CX LogD: 9.85 |
Aromatic Rings: 1 | Heavy Atoms: 35 | QED Weighted: 0.38 | Np Likeness Score: 1.69 |
1. Lin HS, Rampersaud AA, Archer RA, Pawlak JM, Beavers LS, Schmidt RJ, Kauffman RF, Bensch WR, Bumol TF, Apelgren LD.. (1995) Synthesis and biological evaluation of a new series of sterols as potential hypocholesterolemic agents., 38 (2): [PMID:7830271] [10.1021/jm00002a010] |
Source(1):